Cargando…

Editorial: Novel Biomarkers for Type 2 Diabetes

Detalles Bibliográficos
Autores principales:	Ahluwalia, Tarunveer S., Kilpeläinen, Tuomas O., Singh, Sandeep, Rossing, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776920/ https://www.ncbi.nlm.nih.gov/pubmed/31611845 http://dx.doi.org/10.3389/fendo.2019.00649

Ejemplares similares

Editorial: The Role of Genetic and Lifestyle Factors in Metabolic Diseases
por: Ahmad, Shafqat, et al.
Publicado: (2019)

Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Is Associated With Disturbances in TCA, Lipid, and Glucose Metabolism
por: Hansen, Christian S., et al.
Publicado: (2022)

Multiomics signatures of type 1 diabetes with and without albuminuria
por: Clos-Garcia, Marc, et al.
Publicado: (2022)

Metabolomic Assessment Reveals Alteration in Polyols and Branched Chain Amino Acids Associated With Present and Future Renal Impairment in a Discovery Cohort of 637 Persons With Type 1 Diabetes
por: Tofte, Nete, et al.
Publicado: (2019)

Editorial: With obesity becoming the new normal, what should we do? ‐Volume II
por: Tziomalos, Konstantinos, et al.
Publicado: (2022)

The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus
por: Puig-Jové, Carlos, et al.
Publicado: (2022)

Editorial: Pharmacoepidemiology in Diabetes Mellitus and its Complications: Focus on Response to Medications
por: Mohammadi Jouabadi, Soroush, et al.
Publicado: (2022)

Four missense genetic variants in CUBN are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes: A genetic association study in Europeans
por: Uglebjerg, Nicoline, et al.
Publicado: (2023)

Editorial: Optimizing Exercise for the Prevention and Treatment of Type 2 Diabetes
por: Karstoft, Kristian, et al.
Publicado: (2018)

Editorial: The link between obesity, type 2 diabetes, and mitochondria
por: Luo, Moulun, et al.
Publicado: (2023)

Editorial: Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
por: Luo, Jian-Quan, et al.
Publicado: (2023)

Carotid‐Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus
por: Tougaard, Ninna Hahn, et al.
Publicado: (2020)

Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
por: Bjerre-Christensen, Theis, et al.
Publicado: (2021)

Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes
por: Tofte, Nete, et al.
Publicado: (2019)

Editorial: Secreted proteins as novel biomarkers and therapeutic targets in NAFLD
por: Xiong, Xuelian
Publicado: (2023)

Editorial: The Role of Sphingolipid Metabolism in the Development of Type 2 Diabetes and Obesity
por: Blachnio-Zabielska, Agnieszka, et al.
Publicado: (2022)

Editorial: Non-insulin hypoglycemic drugs in type 2 diabetes remission
por: Guo, Kai-heng, et al.
Publicado: (2023)

Editorial: Physical Activity and Type 1 Diabetes
por: Jendle, Johan H., et al.
Publicado: (2019)

Editorial: Novel biomarkers and extracellular vesicles in endocrine hypertension and related disorders
por: Carvajal, Cristian A., et al.
Publicado: (2023)

Editorial: Revisiting cellular metabolism and type 1 diabetes
por: Chandra, Vikash, et al.
Publicado: (2023)

Editorial: Cell Transplantation in Diabetes: Cell-Based Immunotherapy for Type 1 Diabetes
por: Wei, Lingling, et al.
Publicado: (2022)

Editorial: Heterogeneity of clinical phenotypes in type 1 diabetes and of beta cell deterioration in type 1 diabetes
por: Li, Xia, et al.
Publicado: (2023)

Editorial: Footprints of Immune Cells in the Type 1 Diabetic Pancreas
por: Brusko, Todd M., et al.
Publicado: (2021)

Non-Coding RNA as Biomarkers for Type 2 Diabetes Development and Clinical Management
por: Chi, Tiange, et al.
Publicado: (2021)

Integrated lipids biomarker of the prediabetes and type 2 diabetes mellitus Chinese patients
por: Yang, Jiaying, et al.
Publicado: (2023)

The Association Between Cardiovascular Autonomic Function and Changes in Kidney and Myocardial Function in Type 2 Diabetes and Healthy Controls
por: Laursen, Jens Christian, et al.
Publicado: (2021)

Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
por: Dejenie, Tadesse Asmamaw, et al.
Publicado: (2023)

Editorial: Diabetes and aging
por: Barbosa, Helena Cristina de Lima
Publicado: (2022)

Editorial: Technologies for diabetes
por: Salzano, Giuseppina, et al.
Publicado: (2023)

Biomarkers for Detecting Kidney Dysfunction in Type-2 Diabetics and Diabetic Nephropathy Subjects: A Case-Control Study to Identify Potential Biomarkers of DN to Stratify Risk of Progression in T2D Patients
por: Harkin, Carla, et al.
Publicado: (2022)

Editorial: Conditions and results of effective glycemic control in children with type 1 diabetes
por: Scaramuzza, Andrea Enzo, et al.
Publicado: (2022)

Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria
por: Winther, Signe Abitz, et al.
Publicado: (2021)

Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [(64)Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial
por: Jensen, Jacob K., et al.
Publicado: (2021)

Editorial: The Changing Panorama of Diabetes Outcomes: Novel Complications and Novelties in Classical Complication
por: Siddiqui, Khalid, et al.
Publicado: (2022)

Editorial: Diabetes and bone - from cell to human
por: Vestergaard, Peter, et al.
Publicado: (2022)

The Potential Use of DNA Methylation Biomarkers to Identify Risk and Progression of Type 2 Diabetes
por: Gillberg, Linn, et al.
Publicado: (2015)

Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications
por: Willmer, Tarryn, et al.
Publicado: (2018)

Editorial: The gut-pancreas axis in type 1 diabetes – a focus on environmental factors
por: Fløyel, Tina, et al.
Publicado: (2023)

Editorial: Daily challenges around physical exercise, nutrition and medication in type 1 diabetes
por: Moser, Othmar, et al.
Publicado: (2023)

Editorial: Cardiovascular Disease and Diabetes
por: Santulli, Gaetano
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d278n88j685lffaoht6mig87t5